ArriVent BioPharma Reports First Quarter 2026 Financial Results
Go back to ArriVent BioPharma Reports First Quarter 2026 Financial Results| (NASDAQ: AVBP) | Delayed: 28.45 -1.65 (5.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $30.10 | 52 Week High | $ | |||
| Open | $30.16 | 52 Week Low | $ | |||
| Day High | $30.55 | P/E | N/A | |||
| Day Low | $28.43 | EPS | $ | |||
| Volume | 653,155 | |||||

